Results 221 to 230 of about 19,814 (246)

Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia

New England Journal of Medicine, 2020
Frederick J Raal, Kausik K Ray, Wolfgang Koenig   +2 more
exaly  

Evinacumab for Homozygous Familial Hypercholesterolemia

New England Journal of Medicine, 2020
Frederick J Raal, Robert S Rosenson, Laurens F Reeskamp   +2 more
exaly  

Genetic identification of familial hypercholesterolemia within a single U.S. health care system

Science, 2016
Noura S Abul-Husn, Kandamurugu Manickam, Laney K Jones   +2 more
exaly  

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

Nature Genetics, 2003
Marianne Abifadel, Mathilde Varret, Jean-Pierre Rabès   +2 more
exaly  

Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein

Science, 2001
Marcello Arca, Giovanni Zuliani, Renato Fellin   +2 more
exaly  

Predicting Cardiovascular Events in Familial Hypercholesterolemia

Circulation, 2017
Rodrigo Alonso, Cristina Fernández-Pérez, Juan Francisco Sánchez Muñoz Torrero   +2 more
exaly  

Familial hypercholesterolemia.

Journal of the Royal Society of Medicine, 1988
L T, Jensen, F, Skovby, G E, Andersen
  +6 more sources

Low-Density Lipoprotein Cholesterol–Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia

Circulation, 2012
Frederick J Raal
exaly  

Familial Hypercholesterolemia

Journal of Cardiovascular Medicine and Surgery, 2016
Harsh Wardhan, Nitin Aggarwal
openaire   +2 more sources

Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia

Circulation, 2013
Evan A Stein, , Frederick J Raal
exaly